Browse Categories
Exclusive Headlines
SAN FRANCISCO, CA, USA (UroToday.com) -
SAN FRANCISCO, CA, USA (UroToday.com) - Researchers from six medical centers investigated the empiric use of the antibiotic (ciprofloxacin 500 mg given twice daily) to treat 77 asymptomatic males with newly elevated PSA (>2.5 ng/ml) undergoing their first prostate biopsy.
BERKELEY, CA (UroToday.com) - We have recently published an article on the impact of androgen deprivation therapy on depressive symptoms in men with non-metastatic prostate cancer.1
SAN FRANCISCO, CA, USA (UroToday.com) - Researchers at UCSF are investigating novel biomarkers to help predict tumor behavior with greater accuracy.
| Unilateral exophthalmos revealing metastatic prostate cancer - Abstract |
|
|
Last Updated ( Sun, 05 February 2012 )
Login to read more...| Long-term outcomes of open radical retropubic prostatectomy for clinically localized prostate cancer in the prostate-specific antigen era - Abstract |
|
|
Last Updated ( Sun, 05 February 2012 )
Login to read more...| Understanding variation in primary prostate cancer treatment within the Veterans Health Administration - Abstract |
|
|
Last Updated ( Sun, 05 February 2012 )
Login to read more...| Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancer - Abstract |
|
|
Last Updated ( Sun, 05 February 2012 )
Login to read more...| Acceptability and preliminary feasibility of an Internet/CD-ROM-based education and decision program for early-stage prostate cancer patients: Randomized pilot study - Abstract |
|
|
Last Updated ( Sun, 05 February 2012 )
Login to read more...| Explaining racial differences in prostate cancer mortality - Abstract |
|
|
Last Updated ( Sun, 05 February 2012 )
Login to read more...| Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC Map: A prospective large-scale cohort study - Abstract |
|
|
Last Updated ( Mon, 06 February 2012 )
Login to read more...| Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood - Abstract |
|
|
Last Updated ( Mon, 06 February 2012 )
Login to read more...| Adjuvant effect of IV clodronate on the delay of bone metastasis in high-risk prostate cancer patients: A prospective study - Abstract |
|
|
Last Updated ( Mon, 06 February 2012 )
Login to read more...| Focal therapy for localised prostate cancer: Are we asking the correct research questions? - Abstract |
|
|
Last Updated ( Mon, 06 February 2012 )
Login to read more...Subscribe
Editors Corner
Featured Conference
Upcoming Conference
GU Cancers Symposium 2012
February 2 - 4, 2012
San Francisco Marriott Marquis
San Francisco, CA USA
Prostate cancer session highlights sponsored by Bristol-Myers Squibb


